Orbis Allan Gray’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-106,852
Closed -$8.45M – 68
2016
Q3
$8.45M Sell
106,852
-871
-0.8% -$70.8K 0.06% 65
2016
Q2
$8.99M Hold
107,723
– – 0.07% 62
2016
Q1
$9.9M Hold
107,723
– – 0.08% 66
2015
Q4
$10.9M Hold
107,723
– – 0.09% 62
2015
Q3
$10.6M Sell
107,723
-24,178
-18% -$2.69M 0.09% 64
2015
Q2
$15.4M Sell
131,901
-1,161,985
-90% -$127M 0.12% 62
2015
Q1
$127M Sell
1,293,886
-1,272,634
-50% -$129M 1.01% 31
2014
Q4
$242M Sell
2,566,520
-1,691,781
-40% -$175M 1.84% 19
2014
Q3
$453M Sell
4,258,301
-1,888,276
-31% -$185M 3.6% 6
2014
Q2
$510M Buy
6,146,577
+3,501,459
+132% +$273M 4.19% 6
2014
Q1
$187M Buy
2,645,118
+1,939,660
+275% +$152M 1.49% 25
2013
Q4
$53M Sell
705,458
-37,591
-5% -$2.62M 0.37% 54
2013
Q3
$46.7M Sell
743,049
-154,000
-17% -$9.2M 0.35% 48
2013
Q2
$45.9M Hold
897,049
– – 0.37% 46

Other funds holding GILD

Orbis Allan Gray's GILD Position: Q4 2016 in Review

Orbis Allan Gray sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 106,852 shares — an estimated $8.45M sold.

Orbis Allan Gray first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $510M in Q2 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Orbis Allan Gray reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Orbis Allan Gray sold 106,852 Gilead Sciences shares in Q4 2016, an estimated $8.45M.
  • Orbis Allan Gray first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Orbis Allan Gray's Gilead Sciences position peaked at $510M in Q2 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Orbis Allan Gray's 13F filing for Q4 2016, filed 14 Feb 2017.